Albert Einstein College of Medicine Researcher Provides Details of New Studies and Findings in the Area of Disease Progression (Benefit of early oseltamivir therapy for adults hospitalized with influenza A: an observational study).

A recent study conducted by researchers at Albert Einstein College of Medicine in New York City found that early oseltamivir therapy for adults hospitalized with influenza A was associated with a reduced risk of disease progression, including pulmonary and extrapulmonary organ failure and death. The study analyzed 840 influenza-positive patients, with 49% starting oseltamivir treatment on the day of admission and 51% not receiving treatment. Patients treated early had lower peak pulmonary disease severity and lower odds of intensive care unit admission, acute kidney replacement therapy or vasopressor use, and in-hospital death. This research provides valuable insights into the benefits of early antiviral therapy for influenza patients in a hospital setting. [Extracted from the article]